NCT00003461 Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT00003435 Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer Status WITHDRAWN Phase PHASE1
NCT00003434 Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer Status TERMINATED Phase PHASE1
NCT00003432 Immunotherapy in Treating Patients With Metastatic Breast Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00003431 Flt3L in Treating Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00003348 Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain Status COMPLETED Phase PHASE1
NCT00003229 Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal Status COMPLETED Phase PHASE1/PHASE2
NCT00003020 LMB-7 Immunotoxin in Treating Patients With Leptomeningeal Metastases Status COMPLETED Phase PHASE1
NCT00002988 Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma Status COMPLETED Phase PHASE1
NCT00002986 Chemotherapy in Treating Patients With Recurrent Malignant Glioma Status COMPLETED Phase PHASE1
NCT00002754 Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors Status COMPLETED Phase PHASE1
NCT00002753 Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas Status COMPLETED Phase PHASE1
NCT00002752 Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers Status COMPLETED Phase PHASE1/PHASE2
NCT00002751 Monoclonal Antibody Therapy in Treating Patients With Brain Metastases Status COMPLETED Phase PHASE1/PHASE2
NCT00001373 Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics Status RECRUITING Phase N/A